non-White ethnic and racial populations want dementia care providers who understand their experiences and backgrounds, however, only 1 in 3 U.S. physicians are Black, American Indian or Alaska Native, Hispanic or Asian. Future Alzheimer’s and dementia research can be strengthened by increasing the diversity of investigators and professionals who conduct clinical trial and population health research as well. of how racial and ethnic differences may affect the effectiveness and safety of potential new treatments. The Alzheimer’s Association is working with several community-based organizations and other groups to educate and engage diverse communities about Alzheimer’s disease and care and support services it provides. National partnerships include: The African Methodist Episcopal Church The Alzheimer’s Association and NIH are co-funding the Institute on Methods and Protocols for Advancement of Clinical Trials in Alzheimer’s disease and related dementias (IMPACTAD) program -- an innovative program to increase diversity in dementia research launched in fall of 2020. Seventy percent or the participants were women and more than half self-identified as people of color. • Engage, recruit and retain diverse populations in Alzheimer’s and dementia research and clinical trials. Without appropriate representation of Black, Hispanic, Asian and Native Americans in Alzheimer’s clinical trials and research, it is impossible to get a complete understanding The National Hispanic Council on Aging SAGE (Advocacy & Services for LGBTQ Elders) The Thurgood Marshall College Fund Tzu Chi USA If you would like to learn how to get involved to help spread awareness, share your story and improve dementia care in your community, visit alz.org/iowa. Full text of the 2021 Alzheimer’s Disease Facts and Figures report, including the accompanying special report, “Race, Ethnicity and Alzheimer’s in America,” can be viewed at alz.org/facts. The URBAN EXPERIENCE | 2021 27
28 Publizr Home